DOM-ATOMOXETINE DIN 02390485
Status: Cancelled Post Market
Holder: DOMINION PHARMACAL
Molecule: ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE)
Health Canada record
| Active ingredient(s) | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06BA09 ATOMOXETINE |
| Original market date | 23-Apr-2013 |
| Current status date | 09-May-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Dominion Pharmacal — licence 100967, currently licensed, last inspection rating C (2023-03-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02318024 | APO-ATOMOXETINE | APOTEX INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 10 MG | Marketed |
| 02318032 | APO-ATOMOXETINE | APOTEX INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Marketed |
| 02318040 | APO-ATOMOXETINE | APOTEX INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG | Marketed |
| 02318059 | APO-ATOMOXETINE | APOTEX INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Marketed |
| 02318083 | APO-ATOMOXETINE | APOTEX INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 100 MG | Marketed |
| 02318075 | APO-ATOMOXETINE | APOTEX INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 80 MG | Marketed |
| 02318067 | APO-ATOMOXETINE | APOTEX INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Marketed |
| 02381052 | PMS-ATOMOXETINE | PHARMASCIENCE INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Marketed |
| 02381060 | PMS-ATOMOXETINE | PHARMASCIENCE INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Marketed |
| 02381028 | PMS-ATOMOXETINE | PHARMASCIENCE INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 10 MG | Marketed |
| 02381036 | PMS-ATOMOXETINE | PHARMASCIENCE INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Marketed |
| 02381044 | PMS-ATOMOXETINE | PHARMASCIENCE INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG | Marketed |
| 02396904 | PRO-ATOMOXETINE | PRO DOC LIMITEE | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 10 MG | Marketed |
| 02396947 | PRO-ATOMOXETINE | PRO DOC LIMITEE | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Marketed |
| 02396939 | PRO-ATOMOXETINE | PRO DOC LIMITEE | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Marketed |
| 02396920 | PRO-ATOMOXETINE | PRO DOC LIMITEE | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG | Marketed |
| 02396912 | PRO-ATOMOXETINE | PRO DOC LIMITEE | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Marketed |
| 02405970 | RIVA-ATOMOXETINE | LABORATOIRE RIVA INC. | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Marketed |
| 02405989 | RIVA-ATOMOXETINE | LABORATOIRE RIVA INC. | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG | Marketed |
| 02406004 | RIVA-ATOMOXETINE | LABORATOIRE RIVA INC. | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Marketed |
| 02405962 | RIVA-ATOMOXETINE | LABORATOIRE RIVA INC. | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 10 MG | Marketed |
| 02386429 | SANDOZ ATOMOXETINE | SANDOZ CANADA INCORPORATED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Marketed |
| 02386488 | SANDOZ ATOMOXETINE | SANDOZ CANADA INCORPORATED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 100 MG | Marketed |
| 02386461 | SANDOZ ATOMOXETINE | SANDOZ CANADA INCORPORATED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 80 MG | Marketed |
| 02386453 | SANDOZ ATOMOXETINE | SANDOZ CANADA INCORPORATED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Marketed |
| 02386445 | SANDOZ ATOMOXETINE | SANDOZ CANADA INCORPORATED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Marketed |
| 02386437 | SANDOZ ATOMOXETINE | SANDOZ CANADA INCORPORATED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG | Marketed |
| 02386410 | SANDOZ ATOMOXETINE | SANDOZ CANADA INCORPORATED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 10 MG | Marketed |
| 02314541 | TEVA-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 10 MG | Marketed |
| 02314568 | TEVA-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Marketed |
| 02314576 | TEVA-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG | Marketed |
| 02314584 | TEVA-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Marketed |
| 02314592 | TEVA-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Marketed |
| 02362511 | TEVA-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 80 MG | Marketed |
| 02390515 | DOM-ATOMOXETINE | DOMINION PHARMACAL | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Cancelled Post Market |
| 02390493 | DOM-ATOMOXETINE | DOMINION PHARMACAL | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Cancelled Post Market |
| 02390477 | DOM-ATOMOXETINE | DOMINION PHARMACAL | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Cancelled Pre Market |
| 02390469 | DOM-ATOMOXETINE | DOMINION PHARMACAL | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 10 MG | Cancelled Pre Market |
| 02378949 | MYLAN-ATOMOXETINE | MYLAN PHARMACEUTICALS ULC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG | Cancelled Post Market |
| 02378930 | MYLAN-ATOMOXETINE | MYLAN PHARMACEUTICALS ULC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Cancelled Post Market |
| 02378981 | MYLAN-ATOMOXETINE | MYLAN PHARMACEUTICALS ULC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 100 MG | Cancelled Post Market |
| 02378973 | MYLAN-ATOMOXETINE | MYLAN PHARMACEUTICALS ULC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 80 MG | Cancelled Post Market |
| 02378965 | MYLAN-ATOMOXETINE | MYLAN PHARMACEUTICALS ULC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Cancelled Post Market |
| 02378957 | MYLAN-ATOMOXETINE | MYLAN PHARMACEUTICALS ULC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Cancelled Post Market |
| 02404672 | PMS-ATOMOXETINE | PHARMASCIENCE INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 100 MG | Cancelled Pre Market |
| 02404664 | PMS-ATOMOXETINE | PHARMASCIENCE INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 80 MG | Cancelled Pre Market |
| 02362457 | RATIO-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 10 MG | Cancelled Pre Market |
| 02362481 | RATIO-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Cancelled Pre Market |
| 02362503 | RATIO-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Cancelled Pre Market |
| 02362465 | RATIO-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Cancelled Pre Market |
| 02362473 | RATIO-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG | Cancelled Pre Market |
| 02405997 | RIVA-ATOMOXETINE | LABORATOIRE RIVA INC. | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Dormant |
| 02262819 | STRATTERA | ELI LILLY CANADA INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 18 MG | Cancelled Post Market |
| 02262800 | STRATTERA | ELI LILLY CANADA INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 10 MG | Cancelled Post Market |
| 02279355 | STRATTERA | ELI LILLY CANADA INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 100 MG | Cancelled Post Market |
| 02279347 | STRATTERA | ELI LILLY CANADA INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 80 MG | Cancelled Post Market |
| 02262843 | STRATTERA | ELI LILLY CANADA INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 60 MG | Cancelled Post Market |
| 02262835 | STRATTERA | ELI LILLY CANADA INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 40 MG | Cancelled Post Market |
| 02262827 | STRATTERA | ELI LILLY CANADA INC | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 25 MG | Cancelled Post Market |
| 02362538 | TEVA-ATOMOXETINE | TEVA CANADA LIMITED | Capsule | ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 13569 | 2012-08-16 | Abbreviated New Drug Submission (ANDS) | New manufacturer and product name |